{"entity":{"id":"nct07629726","kind":"trial","name":"A Phase 1/2 Study of KK2430 in Participants With Hematologic Neoplasms","aka":[],"tldr":"A phase 1/2 trial of KK2430 in advanced solid tumours, run by Kyowa Kirin Co., Ltd., now recruiting.","summary":"A Phase 1/2 Study of KK2430 in Participants With Hematologic Neoplasms is a phase 1/2 interventional study registered as NCT07629726 by Kyowa Kirin Co., Ltd., with 72 participants planned, started 2026-08 and due to reach its primary completion in 2027-04. Interventions recorded: KK2430.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07629726","url":"https://clinicaltrials.gov/study/NCT07629726"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["kyowa-kirin"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07629726","phase":"1/2","setting":"A Phase 1/2, Multicenter, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KK2430 in Participants With Hematologic Neoplasms","sponsor":"Kyowa Kirin Co., Ltd.","enrolled":72,"outcomes":[]},"route":"/trials/nct07629726/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"kyowa-kirin","kind":"company","name":"Kyowa Kirin","route":"/companies/kyowa-kirin/"}]}}